Duchenne Muscular Dystrophy (DMD) is a severe type of muscle wasting disease affecting approximately one in 3,600 to 6,000 males at birth. By early teens many patients are unable to move around by themselves. If untreated DMD typically leads to death in the late teens, but improved care has seen increasing numbers of patients living into adulthood.1
The Duchenne Dash fundraiser, an event organised by the Duchenne UK charity, will be held on 3rd July at Goodwood Race Circuit. Participants will be cycling around the track for 12 hours in an attempt to collectively cycle the equivalent distance around the world (40,000km), in an effort to fundraise for this condition to support research efforts.
An incredible team of Pfizer colleagues have volunteered their time to participate in the Duchenne Dash and do all they can to contribute to such a worthy cause. Anthony, Dan, Eloise, Emma, Harriet, Jim, Dan and Owen have been training hard, clocking up the miles and aiming to raise the ambitious target of £16,000 for the charity.
- National Center for Biotechnology Information. Adult care for Duchenne Muscular Dystrophy in the UK. Dec 2014.
PP-PFE-GBR-4201 / November 2021